InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.19) by 27.46 percent. This is a 26.32 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $3.149 million which beat the analyst consensus estimate of $2.626 million by 19.93 percent. This is a 61.57 percent increase over sales of $1.949 million the same period last year.